Secrets To Successful Development For Emerging Biotechs

Emerging biotechs continue to take the industry by storm with rapid therapeutic innovations. In their quest to find an experienced and capable CDMO partner, they are looking for teams that can accommodate their distinct goals and funding challenges. In a recent webinar hosted by Singota Solutions, Singota’s Senior Director of Business Development and Manufacturing, William Powers, spoke to the challenges that many early-phase biotechs find themselves up against, including access to limited quantities of API and minimal regulatory experience, and how a CDMO can best support them.

In an interactive Q&A session with webinar attendees, Powers spoke to the flexible approaches a CDMO can leverage to accommodate early-phase clients and highlighted Singota’s strategies for upholding rapid timelines. Ready to learn more? Download the full article to read Powers' insightful responses to attendee questions.